Enterprise Therapeutics' Series A - III Round

Enterprise Therapeutics raised a round of funding on November 10, 2016.

Enterprise Therapeutics is a UK-based biopharmaceutical company dedicated to the research and development of novel therapies for the treatment of respiratory diseases.…

Articles about Enterprise Therapeutics' Series A - III Round: